Non-opioid Pain Patches Market To Reach $1.4 Billion By 2030

Non-opioid Pain Patches Market Growth & Trends

The global non-opioid pain patches market size is expected to reach USD 1.4 billion by 2030, expanding at a CAGR of 6.2% during the forecast period, according to a new report by Grand View Research, Inc. Some of the key factors driving the market are rising incidence of pain related disorders and the various benefits offered by these patches over other forms of medication used to alleviate acute and chronic pain.

According to the AAPM, chronic pain affects more individuals than cancer, diabetes, and coronary heart disease combined in the U.S. Estimates from the American Chiropractic Association indicate that American citizens spend at least USD 50 billion every year on back-related ailments. These facts are indicative of the growing need for therapies to alleviate pain globally.

Opioid medications are usually sought for the treatment of pain and related disorders despite resulting in dependence and abuse in majority of patients. The rising addiction to opioid drugs has encouraged many countries to develop alternate therapies to alleviate discomfort. In November 2017, opioid epidemic in the U.S. was declared as a national emergency. Thus, demand for safe and effective therapies that ease the underlying discomfort with reduced adverse effects are sought by governments, thus accelerating the market growth.

According to a new study published by Substance Abuse and Mental Health Services Administration report in 2015, 1 in 3 adults in America were prescribed painkillers by medical providers. Statistics from the same source also indicate that these medications were used more than cigarettes, cigars, and smokeless tobacco combined. Most of these oral medicines fall under the opiate category are usually more prone to be addictive and used in combination with other consumables such as alcohol and other drugs. Growing awareness about the adverse effects associated with these drugs has led to the development of alternatives such as non-opioid pain patches to deliver the same therapeutic effect and aid in pain management.

 Request a free sample copy or view report summary: Non-opioid Pain Patch Market Report

Non-opioid Pain Patches Market Report Highlights

• Licodaine patches held the largest market share of 35.0% in 2024, owing to their established efficacy in alleviating various pain types, including neuropathic and musculoskeletal pain.

• Retail pharmacies dominated the market with a revenue share of 44.6% in 2024. A variety of non-opioid pain patches are available over-the-counter, enabling customers to purchase them without prescriptions.

• North America held the largest revenue share due to local presence of major non-opioid pain patch market players and increasing R&D in the field of pain management to cater to a rising number of patients

• The Asia Pacific region is expected to account for the highest CAGR during the forecast period owing to rise in investments by dominant players in the region and developments in the pharmaceutical industry in emerging countries such as India and China

Non-opioid Pain Patches Market Segmentation

Grand View Research has segmented the global non-opioid pain patches market report based on patch type, distribution channel, and region:

 Non-opioid Pain Patches Patch Type Outlook (Revenue, USD Million, 2018 - 2030)

• Lidocaine Patches

• Diclofenac Patches

• Methyl Salicylate Patches

• Capsaicin Patches

• Ketoprofen Patches

• Others (Herbal, Menthol, etc.)

Non-opioid Pain Patches Distribution Channel Outlook (Revenue, USD Million, 2018 - 2030)

• Retail Pharmacies

• Hospital Pharmacies

• Online Pharmacies

• Others (Supermarkets/Hypermarkets, DTC)

Non-opioid Pain Patches Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America

  • U.S.

  • Canada

  • Mexico

• Europe

  • UK

  • Germany

  • France

  • Italy

  • Spain

  • Denmark

  • Sweden

  • Norway

• Asia Pacific

  • Japan

  • China

  • India

  • Australia

  • South Korea

  • Thailand

• Latin America

  • Brazil

  • Argentina

• Middle East & Africa

  • South Africa

  • Saudi Arabia

  • UAE

  • Kuwait

List of Key Players in Non-opioid Pain Patches Market

• Acorda Therapeutics, Inc.

• Teva Pharmaceutical Industries Ltd.

• GSK plc

• Endo, Inc.

• Hisamitsu Pharmaceutical Co.,Inc.

• IBSA Institut Biochimique SA

• Alkermes

• Teikoku Pharma

• Mylan N.V.